Clinical trial
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Tolerability Of Indiplon Therapy Initiated With Sertraline Versus Sertraline Monotherapy In Subjects With Insomnia And Co-Existing Major Depressive Disorder
NCT00232167 is registered in ClinicalTrials.gov with Neurocrine Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Tolerability Of Indiplon Therapy Initiated With Sertraline Versus Sertraline Monotherapy In Subjects With Insomnia And Co-Existing Major Depressive Disorder
- Lead sponsor
- Neurocrine Biosciences
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- November 30, 2005
- Completion date
- April 30, 2006
- Enrollment
- 380
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
depression, insomnia